EP3810626
PCSK9 ANTAGONIST COMPOUNDS
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
20.6.2019:
23.7.2025:
19739801.9
:
19.6.2039:
19.6.2026
:
PCSK9 ANTAGONIST COMPOUNDS
20.6.2019
23.7.2025
19.6.2026
:
Merck Sharp & Dohme LLC:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
:
WOOD, Harold, B.:
Kenilworth, NJ 07033, US
:
JOSIEN, Hubert, B.:
Kenilworth, NJ 07033, US
:
TUCKER, Thomas, Joseph:
West Point, PA 19486, US
:
KEREKES, Angela, Dawn:
Kenilworth, NJ 07033, US
:
TONG, Ling:
West Point, PA 19486, US
:
WALJI, Abbas, M.:
West Point, PA 19486, US
:
NAIR, Anilkumar, G.:
Kenilworth, NJ 07033, US
:
DING, Fa-Xiang:
Kenilworth, NJ 07033, US
:
BIANCHI, Elisabetta:
600-0040 Pomezia, IT
:
BRANCA, Danila:
600-0400 Pomezia, IT
:
WU, Chengwei:
West Point, PA 19486, US
:
XIONG, Yusheng:
Kenilworth, NJ 07033, US
:
HA, Sookhee, Nicole:
Kenilworth, NJ 07033, US
:
LIU, Jian:
Kenilworth, NJ 07033, US
:
BOGA, Sobhana, Babu:
Kenilworth, NJ 07033, US
:
201862687913 P:
21.6.2018:
US
:
US2019038155:
20.6.2019
:
C07K 7/06, A61K 38/00, C12N 9/64